Trial Profile
ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Boosted or Unboosted Atazanavir
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- Acronyms ATAGLU
- 25 Jun 2014 New trial record